Isbn: 9783031386046 - practical management of thyroid cancer: a multidisciplinary approach (9 risultati)

Perfeziona la tua ricerca

  • Libri (9)

  • Nuovo (9)

a

Fascia di prezzo personalizzata (EUR)

a

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato

      Da: Books Puddle, New York, NY, U.S.A.Books Puddle

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 246,82

      EUR 3,46 spedizione 
      Spedito in U.S.A.

      Quantità: 4 disponibili

      Condizione: New.

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato

      Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 255,87

      EUR 37,99 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists.

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato

      Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 316,70

      EUR 29,23 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 1 disponibili

      hardcover. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 142,27

      EUR 11,00 spedizione 
      Spedito da Italia a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: new. Questo è un articolo print on demand.

    • Lingua: Inglese

      Editore: Springer International Publishing, 2024

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: moluna, Greven, Germaniamoluna

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 149,85

      EUR 48,99 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covid-19 pandemic and thyroid cancer -- lessons learntArtificial intelligence in thyroid cancerGenomics based platform trials, tumour agnostic drugsDr Ujjal Mallick, MBBS&nbspMS&nbspFRCPE (Hon)&nbspFRCP (Hon) FRCR&nbspCons.

    • Lingua: Inglese

      Editore: Springer International Publishing Nov 2023, 2023

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 181,89

      EUR 23,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 2 disponibili

      Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists. 416 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, Palgrave Macmillan Mär 2024, 2024

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 181,89

      EUR 60,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Draws on international experience across many disciplines offering a practical approach to the topicExamines the latest advances in surgical and non-surgical managementDiscusses molecular studies and translational research and how they have transformed the diagnosis and management of thyroid cancerAddresses current challenges and areas of controversy such as low risk thyroid cancer and papillary microcarcinomaSpringer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 416 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: Majestic Books, Hounslow, Regno UnitoMajestic Books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 257,24

      EUR 7,60 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. Print on Demand.

    • Lingua: Inglese

      Editore: Springer, 2024

      3031386043 / 9783031386046

      • Rilegato
      • Print on Demand

      Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 264,21

      EUR 9,95 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. PRINT ON DEMAND.